INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

ALMSALUMIS INC.

CIK 0001847367

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells0 / 6
Max Insider Score36
Connections7with evidence

ALMS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
PS
Pangali SanamChief Legal Officer
ALMSALUMIS INC.
Open-market sale
SELL$2,165
332 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Hardiman Roy C.Chief Business & Strategy Ofcr · Nov 4, 2026
  • ← Insider ofevidence
    Pangali SanamChief Legal Officer · Jan 28, 2026
  • ← Insider ofevidence
    Goldstein David MChief Scientific Officer · Jan 28, 2026
36
BC
Bradley Mark ChristopherChief Development Officer
ALMSALUMIS INC.
Open-market sale
SELL
$4,062
623 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

36
DJ
Drappa JornChief Medical Officer
ALMSALUMIS INC.
Open-market sale
SELL$3,866
593 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

36
SR
Schroer John R.Chief Financial Officer
ALMSALUMIS INC.
Open-market sale
SELL$5,177
794 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

36
GM
Goldstein David MChief Scientific Officer
ALMSALUMIS INC.
Open-market sale
SELL$4,101
629 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

36
HC
Hardiman Roy C.Chief Business & Strategy Ofcr
ALMSALUMIS INC.
Open-market sale
SELL$4,251
652 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
SR
Schroer John R.Chief Financial Officer
ALMSALUMIS INC.
Grant or award
A—
202.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

9
BC
Bradley Mark ChristopherChief Development Officer
ALMSALUMIS INC.
Grant or award
A—
190.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

9
DJ
Drappa JornChief Medical Officer
ALMSALUMIS INC.
Grant or award
A—
221.4K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

9
GM
Goldstein David MChief Scientific Officer
ALMSALUMIS INC.
Grant or award
A—
216.7K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

9
PS
Pangali SanamChief Legal Officer
ALMSALUMIS INC.
Grant or award
A—
186.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Bradley Mark ChristopherChief Development Officer · Jan 28, 2026
  • ← Insider ofevidence
    Drappa JornChief Medical Officer · Jan 28, 2026
  • ← Insider ofevidence
    Schroer John R.Chief Financial Officer · Jan 28, 2026